Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › IN › Richmond › NPI 1063457380
Hospital

Reid Hospital & Health Care Services, INC

Reid Hospital & Health Care Services, INC was paid $66.77M by Medicaid between Jan 2018 and Nov 2024, across 242 billing codes. Its largest line is T2048, Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem — 11% of everything it billed.

33Billing provider infoREID HOSPITAL & HEALTH CARE SERVICES, INC
RICHMOND, IN 47374
33aNPI1063457380assigned 06/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$66.77M
24GClaims929,064
24DCodes billed242
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers

Next to other General Acute Care Hospital providers in Indiana

Rank by total paid#4 of 69
Median peer was paid$9.76M
This provider vs. median6.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201888,313$1.71M
201999,498$5.37M
2020105,563$7.42M
2021162,234$11.60M
2022201,656$15.89M
2023164,693$14.57M
2024incomplete107,107$10.21M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T2048 Behavioral health; long-term care residential (non-acute care in a residential treatment program where stay is typically longer than 30 days), with room and board, per diem 11% 1,744 615 $7.24M
45380 Colonoscopy, flexible; with biopsy, single or multiple 8.0% 3,573 2,778 $5.35M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.6% 35,179 29,859 $5.04M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 7.1% 9,904 4,296 $4.71M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.2% 40,535 32,993 $4.14M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 6.1% 6,260 4,932 $4.10M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 6.1% 28,696 24,134 $4.07M
99282 Emergency department visit for the evaluation and management, low to moderate severity 5.0% 23,934 20,671 $3.31M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4.1% 42,830 29,424 $2.74M
43249 4.0% 1,335 941 $2.66M
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 3.3% 15,664 4,582 $2.18M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3.1% 34,823 28,015 $2.04M
230 more codes
71045 Radiologic examination, chest; single view 3.0% 15,758 $2.00M
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.8% 14,689 $1.89M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.1% 15,975 $1.43M
71046 Radiologic examination, chest; 2 views 1.5% 10,128 $1.00M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.4% 27,578 $904K
59025 Fetal non-stress test 1.3% 3,505 $843K
64483 1.1% 892 $754K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 2,300 $679K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 4,428 $603K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 718 $591K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 2,833 $463K
64635 <1% 265 $440K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 6,408 $425K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 105,930 $417K
64493 <1% 429 $373K
80053 Comprehensive metabolic panel <1% 63,245 $326K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 9,631 $293K
96361 Intravenous infusion, hydration; each additional hour <1% 4,071 $257K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 151 $251K
70450 Computed tomography, head or brain; without contrast material <1% 2,773 $250K
36415 Collection of venous blood by venipuncture <1% 126,122 $249K
43450 <1% 1,942 $246K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 6,675 $212K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 108 $207K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 3,209 $200K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 9,223 $198K
95811 <1% 88 $178K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 6,912 $177K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 4,828 $167K
80050 General health panel <1% 872 $147K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 465 $144K
64636 <1% 286 $143K
62323 <1% 387 $130K
84484 <1% 18,938 $129K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 5,218 $116K
80048 Basic metabolic panel (calcium, ionized) <1% 27,570 $115K
96375 Therapeutic injection; each additional sequential IV push <1% 13,198 $112K
64494 <1% 365 $97K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 90 $93K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,263 $72K
87088 <1% 13,315 $71K
80061 Lipid panel <1% 8,363 $70K
43235 <1% 73 $65K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,329 $65K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,314 $64K
99222 Initial hospital care, per day, moderate complexity <1% 108 $63K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 3,181 $60K
78815 Positron emission tomography (PET) for limited area imaging <1% 64 $60K
64721 <1% 67 $59K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 237 $52K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 92 $42K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 261 $41K
97605 <1% 307 $38K
84443 Thyroid stimulating hormone (TSH) <1% 4,806 $38K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 2,897 $37K
86780 <1% 3,547 $36K
11045 <1% 282 $34K
93458 <1% 13 $34K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 1,859 $34K
99239 Hospital discharge day management, more than 30 minutes <1% 58 $30K
36475 <1% 22 $29K
81001 <1% 17,024 $28K
77336 <1% 235 $28K
86480 <1% 479 $28K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 155 $27K
83690 <1% 8,082 $25K
83970 <1% 2,087 $23K
80074 <1% 518 $23K
76830 Ultrasound, transvaginal <1% 120 $22K
74018 <1% 205 $21K
29581 <1% 272 $20K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 410 $19K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 94 $19K
45390 <1% 34 $17K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 947 $16K
82728 <1% 1,860 $16K
86850 <1% 3,544 $15K
76819 Fetal biophysical profile; without non-stress testing <1% 186 $15K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 526 $15K
86762 <1% 1,329 $15K
86803 <1% 1,310 $14K
84439 <1% 2,624 $14K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 187 $13K
81025 <1% 2,174 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 889 $13K
J7030 Infusion, normal saline solution , 1000 cc <1% 1,147 $12K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 75 $12K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 39 $12K
96417 <1% 136 $12K
93017 <1% 111 $11K
87522 Neg quan hep c or qual rna <1% 310 $11K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 13 $11K
94060 <1% 185 $10K
99214 Doctor's office visit, returning patient (more involved) <1% 267 $9K
76536 <1% 76 $9K
84702 <1% 953 $9K
82607 <1% 978 $9K
83550 <1% 1,752 $9K
88346 <1% 19 $9K
87340 <1% 1,279 $8K
G0378 Hospital observation service, per hour <1% 138 $8K
83880 <1% 474 $8K
83735 <1% 2,646 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 1,154 $8K
71250 <1% 50 $7K
83540 <1% 1,755 $7K
82746 <1% 767 $7K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 134 $6K
84703 <1% 1,084 $6K
64495 <1% 17 $6K
85027 <1% 2,334 $6K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 44 $6K
87634 <1% 95 $6K
87081 <1% 778 $5K
84100 <1% 2,546 $5K
A4649 Surgical supply; miscellaneous <1% 8,609 $5K
J7120 Ringers lactate infusion, up to 1000 cc <1% 6,338 $4K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 13 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 29 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,253 $4K
36416 <1% 1,439 $4K
82150 <1% 562 $3K
94762 <1% 23 $3K
86900 <1% 1,382 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 233 $3K
73130 <1% 130 $3K
97035 <1% 24 $3K
J2469 Injection, palonosetron hcl, 25 mcg <1% 301 $3K
86901 <1% 1,380 $3K
96150 <1% 99 $3K
97162 <1% 69 $3K
36591 <1% 42 $3K
87653 <1% 102 $3K
97165 <1% 22 $3K
82947 <1% 898 $2K
86140 <1% 1,113 $2K
82948 <1% 1,380 $2K
83605 <1% 407 $2K
94726 <1% 319 $2K
76775 <1% 63 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 134 $2K
82248 <1% 464 $2K
97161 <1% 38 $2K
80069 <1% 837 $2K
80076 <1% 447 $2K
83655 <1% 164 $2K
97166 <1% 15 $2K
71275 Computed tomographic angiography, chest, with contrast material <1% 28 $2K
85379 <1% 327 $2K
82570 <1% 620 $1K
73630 <1% 69 $1K
72125 Computed tomography, cervical spine; without contrast material <1% 30 $1K
93922 <1% 45 $1K
85652 <1% 732 $1K
84460 <1% 409 $1K
96367 <1% 25 $1K
77003 <1% 729 $1K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 54 $998.40
82565 <1% 335 $978.67
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 27 $959.82
83615 <1% 441 $947.40
81003 <1% 741 $933.90
84156 <1% 560 $885.13
86200 <1% 129 $827.86
87510 <1% 47 $815.88
87480 <1% 47 $815.88
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,307 $751.34
87660 <1% 47 $736.28
84153 <1% 125 $732.07
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 2,620 $727.47
86038 <1% 121 $712.89
93971 <1% 26 $697.04
86225 <1% 100 $686.79
J2704 Injection, propofol, 10 mg <1% 2,664 $678.68
85610 <1% 352 $645.95
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,676 $625.34
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 12 $583.76
J1453 Injection, fosaprepitant, 1 mg <1% 27 $550.50
82950 <1% 120 $527.15
96376 <1% 98 $515.97
82550 <1% 162 $506.76
94729 <1% 356 $482.88
87641 <1% 20 $480.82
J2270 Injection, morphine sulfate, up to 10 mg <1% 538 $453.12
87077 <1% 104 $445.08
96151 <1% 114 $440.64
96152 <1% 44 $440.64
86431 <1% 131 $410.26
87186 <1% 98 $398.92
83520 <1% 20 $339.23
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 45 $252.72
C1726 Catheter, balloon dilatation, non-vascular <1% 674 $243.54
85046 <1% 41 $237.93
J3490 Unclassified drugs <1% 142 $234.37
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 45 $221.62
82043 <1% 58 $204.77
86235 <1% 15 $173.79
84550 <1% 118 $172.99
88142 <1% 13 $157.08
85007 <1% 64 $156.69
83525 <1% 13 $137.16
82172 <1% 14 $129.16
82784 <1% 19 $124.69
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 456 $112.77
J2785 Injection, regadenoson, 0.1 mg <1% 13 $94.56
86704 <1% 17 $82.26
J3010 Injection, fentanyl citrate, 0.1 mg <1% 622 $55.44
72202 <1% 13 $54.00
82962 <1% 68 $33.99
J0690 Injection, cefazolin sodium, 500 mg <1% 28 $27.72
81596 <1% 14 $17.75
96373 0% 16 $0.00
J1040 Injection, methylprednisolone acetate, 80 mg 0% 274 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 159 $0.00
A9609 Fludeoxyglucose f18 up to 15 millicuries 0% 32 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 88 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 37 $0.00
98961 0% 12 $0.00
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 0% 1,951 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 65 $0.00
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 89 $0.00
J1644 Injection, heparin sodium, per 1000 units 0% 48 $0.00
88312 0% 33 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 231 $0.00
99152 0% 25 $0.00
A9575 Injection, gadoterate meglumine, 0.1 ml 0% 21 $0.00
0100U 0% 41 $0.00
C1776 Joint device (implantable) 0% 21 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 22 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 16 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKINYON, CRAIG (PRESIDENT - REID HOSPITAL)
Same official

Other billing entities under KINYON, CRAIG

Full network →
ProviderLocationPaid
Reid Physician Associates, INC.Richmond, IN$66.40M
Reid Physician Associates, INC.Cambridge City, IN$2.34M
Reid Hospital & Health Care Services, INCRichmond, IN$352K
Reid Hospital & Health Care Services INCRichmond, IN$312K
Reid Hospital & Health Care Services, INC.Richmond, IN$224K
Reid Hospital & Health Care Services, INC.Richmond, IN$144K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.